NYSE American - Delayed Quote USD

Zomedica Corp. (ZOM)

0.1330 +0.0029 (+2.23%)
At close: April 26 at 4:00 PM EDT
0.1338 +0.00 (+0.60%)
After hours: April 26 at 7:56 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ZOM

Recent News: ZOM

View More
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
ACCESSWIRE 17 days ago
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ACCESSWIRE 25 days ago
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
ACCESSWIRE last month
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform

Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
ACCESSWIRE last month
Zomedica Provides NYSE American Listing Update

Zomedica Provides NYSE American Listing Update
ACCESSWIRE last month
Sidoti Events, LLC's Virtual March Small-Cap Conference

Sidoti Events, LLC's Virtual March Small-Cap Conference
ACCESSWIRE last month
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences

Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
ACCESSWIRE last month
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
ACCESSWIRE last month
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024

Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
ACCESSWIRE last month
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences

Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
ACCESSWIRE 2 months ago
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
ACCESSWIRE 2 months ago
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET

Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
ACCESSWIRE 2 months ago
View More

Related Tickers

SENS Senseonics Holdings, Inc.
0.4157
-0.60%
 
BIOL BIOLASE, Inc.
0.1480
0.00%
 
SINT Sintx Technologies, Inc.
0.0404
+10.38%
 
BTCY Biotricity, Inc.
1.2800
-1.54%
 
HSCS Heart Test Laboratories, Inc.
0.0974
-2.50%
 
ASXC Asensus Surgical, Inc.
0.2490
+3.32%
 
NUWE Nuwellis, Inc.
0.1678
-41.94%
 
CATX Perspective Therapeutics, Inc.
1.5800
-1.25%
 
PACB Pacific Biosciences of California, Inc.
1.4700
+6.52%
 
NSPR InspireMD, Inc.
2.0000
+5.82%